Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 2/Phase 3)
Adenomatous Polyposis Coli (Phase 2)
Ascites (Phase 2)
Crohn Disease (Phase 4)
Deglutition Disorders (Early Phase 1)
Diarrhea (Phase 2/Phase 3)
Drug Resistance, Bacterial (Phase 2)
Fatty Liver (Phase 1)
Hepatic Encephalopathy (Phase 3)
Hirschsprung Disease (Phase 2)
Inflammatory Bowel Diseases (Phase 3)
Intestinal Neoplasms (Early Phase 1)
Irritable Bowel Syndrome (Phase 4)
Klebsiella pneumoniae (Phase 1/Phase 2)
Liver Cirrhosis (Phase 2/Phase 3)
Mental Disorders (Phase 2)
Osteoporosis (Phase 2)
Peritonitis (Phase 2/Phase 3)
Probiotics (Phase 4)
Rectal Neoplasms (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue